Skip to content

About us
Science
Pipeline
Partnering
Publications

About us
Science
Pipeline
Partnering
Publications

Pipeline

Clinical‑stage icerguastat assets available for licensing or partnership

Icerguastat in ALS

Icerguastat in CMT

Enemsa Pharma pioneers a new generation of neuroprotective therapies that restore cellular homeostasis through proteostasis modulation, mitophagy enhancement and mitochondrial protection, as standalone treatments and in combination with synergistic partner therapies for neurodegenerative diseases.

Quick links

About us
Partnering
Legal information

About us
Partnering
Legal information

Get in touch

Email: contact@enemsapharma.com
Phone: +33 6 07 08 60 98

© 2026 All Rights Reserved.